Jonathan Serody, MD (IMAGE)
Caption
“Allogeneic transplants can be very effective, and potentially lifesaving, but not all immune cells given to a recipient are reproduced from donor cells,” said Jonathan Serody, MD. “Innate type 2 lymphoid cells are often poorly generated once transplanted in a recipient, and the ILC2s that appear to deviate from their innate programming are the cells that cause more problems after a transplant, which is why we chose them as our focus.”
Credit
UNC Lineberger Comprehensive Cancer Center
Usage Restrictions
None
License
Original content